145 related articles for article (PubMed ID: 28576211)
1. Morpho-functional analysis of Stargardt Disease for reading.
Sasso P; Scupola A; Silvestri V; Amore FM; Abed E; Calandriello L; Grimaldi G; Caporossi A
Can J Ophthalmol; 2017 Jun; 52(3):287-294. PubMed ID: 28576211
[TBL] [Abstract][Full Text] [Related]
2. Morpho-functional correlation of fundus autofluorescence in Stargardt disease.
Parodi MB; Iacono P; Triolo G; La Spina C; Zucchiatti I; Cicinelli MV; Borrelli E; Manitto MP; Martina E; Bandello F
Br J Ophthalmol; 2015 Oct; 99(10):1354-9. PubMed ID: 25837607
[TBL] [Abstract][Full Text] [Related]
3. Multimodal analysis of the Preferred Retinal Location and the Transition Zone in patients with Stargardt Disease.
Verdina T; Greenstein VC; Sodi A; Tsang SH; Burke TR; Passerini I; Allikmets R; Virgili G; Cavallini GM; Rizzo S
Graefes Arch Clin Exp Ophthalmol; 2017 Jul; 255(7):1307-1317. PubMed ID: 28365912
[TBL] [Abstract][Full Text] [Related]
4. Characterization of stargardt disease using polarization-sensitive optical coherence tomography and fundus autofluorescence imaging.
Ritter M; Zotter S; Schmidt WM; Bittner RE; Deak GG; Pircher M; Sacu S; Hitzenberger CK; Schmidt-Erfurth UM;
Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6416-25. PubMed ID: 23882696
[TBL] [Abstract][Full Text] [Related]
5. En Face Spectral-Domain Optical Coherence Tomography for the Monitoring of Lesion Area Progression in Stargardt Disease.
Melillo P; Testa F; Rossi S; Di Iorio V; Orrico A; Auricchio A; Simonelli F
Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT247-52. PubMed ID: 27409479
[TBL] [Abstract][Full Text] [Related]
6. Peripheral Visual Fields in ABCA4 Stargardt Disease and Correlation With Disease Extent on Ultra-widefield Fundus Autofluorescence.
Abalem MF; Otte B; Andrews C; Joltikov KA; Branham K; Fahim AT; Schlegel D; Qian CX; Heckenlively JR; Jayasundera T
Am J Ophthalmol; 2017 Dec; 184():181-188. PubMed ID: 29038010
[TBL] [Abstract][Full Text] [Related]
7. The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies: Design and Baseline Characteristics: ProgStar Report No. 1.
Strauss RW; Ho A; Muñoz B; Cideciyan AV; Sahel JA; Sunness JS; Birch DG; Bernstein PS; Michaelides M; Traboulsi EI; Zrenner E; Sadda S; Ervin AM; West S; Scholl HP;
Ophthalmology; 2016 Apr; 123(4):817-28. PubMed ID: 26786511
[TBL] [Abstract][Full Text] [Related]
8. Quantifying the Rate of Ellipsoid Zone Loss in Stargardt Disease.
Cai CX; Light JG; Handa JT
Am J Ophthalmol; 2018 Feb; 186():1-9. PubMed ID: 29126757
[TBL] [Abstract][Full Text] [Related]
9. Macular Sensitivity Measured With Microperimetry in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 7.
Schönbach EM; Wolfson Y; Strauss RW; Ibrahim MA; Kong X; Muñoz B; Birch DG; Cideciyan AV; Hahn GA; Nittala M; Sunness JS; Sadda SR; West SK; Scholl HPN;
JAMA Ophthalmol; 2017 Jul; 135(7):696-703. PubMed ID: 28542693
[TBL] [Abstract][Full Text] [Related]
10. Microperimetric assessment of the two optical coherence tomography subtypes of acute macular neuroretinopathy.
Battaglia Parodi M; Iacono P; Panico D; Cascavilla M; Bandello F
Clin Exp Ophthalmol; 2015; 43(7):637-42. PubMed ID: 25752249
[TBL] [Abstract][Full Text] [Related]
11. Correlation between photoreceptor layer integrity and visual function in patients with Stargardt disease: implications for gene therapy.
Testa F; Rossi S; Sodi A; Passerini I; Di Iorio V; Della Corte M; Banfi S; Surace EM; Menchini U; Auricchio A; Simonelli F
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4409-15. PubMed ID: 22661472
[TBL] [Abstract][Full Text] [Related]
12. Prognostication in Stargardt Disease Using Fundus Autofluorescence: Improving Patient Care.
Daich Varela M; Laich Y; Hashem SA; Mahroo OA; Webster AR; Michaelides M
Ophthalmology; 2023 Nov; 130(11):1182-1190. PubMed ID: 37331482
[TBL] [Abstract][Full Text] [Related]
13. The absence of fundus abnormalities in Stargardt disease.
Bax NM; Lambertus S; Cremers FPM; Klevering BJ; Hoyng CB
Graefes Arch Clin Exp Ophthalmol; 2019 Jun; 257(6):1147-1157. PubMed ID: 30903310
[TBL] [Abstract][Full Text] [Related]
14. Quantification of peripapillary sparing and macular involvement in Stargardt disease (STGD1).
Burke TR; Rhee DW; Smith RT; Tsang SH; Allikmets R; Chang S; Lazow MA; Hood DC; Greenstein VC
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8006-15. PubMed ID: 21873672
[TBL] [Abstract][Full Text] [Related]
15. Microperimetric correlations of autofluorescence and optical coherence tomography imaging in dry age-related macular degeneration.
Querques L; Querques G; Forte R; Souied EH
Am J Ophthalmol; 2012 Jun; 153(6):1110-5. PubMed ID: 22321805
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers in Usher syndrome: ultra-widefield fundus autofluorescence and optical coherence tomography findings and their correlation with visual acuity and electrophysiology findings.
Mustafic N; Ristoldo F; Nguyen V; Fraser CL; Invernizzi A; Jamieson RV; Grigg JR
Doc Ophthalmol; 2020 Dec; 141(3):205-215. PubMed ID: 32240425
[TBL] [Abstract][Full Text] [Related]
17. [Contribution of multimodal imaging in the various stages of Stargardt disease].
El Matri L; Falfoul Y; Kortli M; Hassairi A; Charfi H; Turki A; Kort F; Chebil A
J Fr Ophtalmol; 2017 Oct; 40(8):666-675. PubMed ID: 28919188
[TBL] [Abstract][Full Text] [Related]
18. A comparison of fundus autofluorescence and retinal structure in patients with Stargardt disease.
Gomes NL; Greenstein VC; Carlson JN; Tsang SH; Smith RT; Carr RE; Hood DC; Chang S
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3953-9. PubMed ID: 19324865
[TBL] [Abstract][Full Text] [Related]
19. Microperimetry Features of Geographic Atrophy Identified With En Face Optical Coherence Tomography.
Pilotto E; Convento E; Guidolin F; Abalsamo CK; Longhin E; Parrozzani R; Midena E
JAMA Ophthalmol; 2016 Aug; 134(8):873-9. PubMed ID: 27253760
[TBL] [Abstract][Full Text] [Related]
20. Microperimetry, fundus autofluorescence, and retinal layer changes in progressing geographic atrophy.
Pilotto E; Benetti E; Convento E; Guidolin F; Longhin E; Parrozzani R; Midena E
Can J Ophthalmol; 2013 Oct; 48(5):386-93. PubMed ID: 24093185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
